PSA heralds QUM award
March 10, 2014
The Pharmaceutical Society of
Australia (PSA) has announced
a jointly sponsored award in
association with Mundipharma
championing quality use of
medicines.
The award will recognise a
pharmacist who has made an
outstanding contribution to the
quality use of medicines through
direct clinical care of consumers
with persistent pain, building
on the pharmacists’ role in pain
management development and
practice support programs.
Liesel Wett, PSA ceo, said
pharmacists had a key role in pain
management and the award would
further encourage development of
this role.
“Pharmacists, like doctors,
have among their professional
responsibilities an important role
in monitoring and questioning
the use of prescription opioids,
and advising patients on the most
effective and safe way to take their
medications, the Royal Australasian
College of Physicians noted in its
Prescription Opioid Policy published
last year.
“It said pharmacists should be
recognised as key stakeholders
in a multidisciplinary group to
implement and evaluate policy.
“To support this role, PSA
has developed a wide range of
resources to support pharmacists
in improving the health outcomes
of people with pain during 2013,
and to address the varied learning
styles of pharmacists.
“These resources include PSA’s
Essential CPE on Neuropathic Pain,
online presentations and podcasts
from PAC13 by last year’s QUM
award winner Alex Page, as well as
Joyce McSwann’s pain management
webinar.”
The PSA said that it recognises
that managing customers’ pains can
be challenging, and has therefore
provided communication education
support - CLICK HERE to access.
For details about the award and
application forms, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Mar 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Mar 14
